Back to 
Verition Fund Management LLC
Verition Fund Management LLC
DSGN
5 quarters
Position history for Verition Fund Management LLC's holdings in Design Therapeutics, Inc.
No. Verition exited its DSGN (Design Therapeutics) position in Q3 2024. Its Q2 2024 13F listed 27,045 shares worth $90,601. Verition first reported DSGN in Q1 2023 and held it in 3 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$254,919
Total Shares Change
-44,180
Quarter-by-Quarter History
Other major holders of DSGN: Citadel Advisors LLC, RA Capital Management, L.P., Point72 Asset Management, L.P.